CAPR vs STE · $1.62B cap vs P/E 25, rev $5.46B
Capricor Therapeutics Inc (CAPR) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
CAPR currently screens at market cap $1.62B. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the CAPR and STE stock pages for the full models.
Not investment advice.